Samil Pharmaceutical Co.,Ltd (KRX:000520)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,290
+200 (1.80%)
At close: Feb 20, 2026

KRX:000520 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
6,4955,137906.141,9033,99215,997
Short-Term Investments
----11,2691,200
Cash & Short-Term Investments
6,4955,137906.141,90315,26117,197
Cash Growth
62.51%466.91%-52.40%-87.53%-11.26%-42.20%
Accounts Receivable
34,49735,02535,81334,18131,01230,137
Other Receivables
164.95754.7186.62123.85120.2357.85
Receivables
34,66235,77935,90034,30431,13330,195
Inventory
33,37034,77032,51124,74224,17724,084
Prepaid Expenses
12,01112,18911,159--767.79
Other Current Assets
2,4953,469638.2713,8326,140279.56
Total Current Assets
89,03291,34681,11574,78176,71172,523
Property, Plant & Equipment
239,655252,893242,198233,946103,39464,808
Long-Term Investments
854.42719.88797.39782.42838.641,066
Other Intangible Assets
3,8574,7081,9173,1361,2951,726
Long-Term Accounts Receivable
28.871,0330000
Long-Term Deferred Tax Assets
-----1,927
Long-Term Deferred Charges
730.82804.2902.04---
Other Long-Term Assets
43,27843,56743,75044,05444,16749,610
Total Assets
377,437395,071370,680356,700226,405191,661
Accounts Payable
16,95019,15921,00413,6608,54110,826
Accrued Expenses
5,1574,0543,2824,01311,1533,842
Short-Term Debt
69,81454,18474,86880,56275,73357,356
Current Portion of Long-Term Debt
35,7489,16449,8304,94016,56016,416
Current Portion of Leases
798.82685.6387.37452.59308.27323.43
Current Income Taxes Payable
328.281,6462,4171,949-1,686
Current Unearned Revenue
139.38123.72112.34179.99171.28171.02
Other Current Liabilities
18,11617,64516,77426,8369,2088,064
Total Current Liabilities
147,052106,660168,675132,592121,67498,684
Long-Term Debt
56,73284,39049,56871,91831,91120,000
Long-Term Leases
1,3541,6591,2251,3871,003306.55
Long-Term Unearned Revenue
1,8966.2736.3866.15222.65385.44
Pension & Post-Retirement Benefits
19,95916,99111,3106,6261,6464,595
Long-Term Deferred Tax Liabilities
5,8827,4939,75213,172--
Other Long-Term Liabilities
1,4711,7482,2865,1204,2024,139
Total Liabilities
234,347218,947242,853230,881160,658128,110
Common Stock
10,84610,8467,6136,8576,7696,695
Additional Paid-In Capital
86,44186,14544,00840,48135,24826,752
Retained Earnings
-3,65519,93728,01926,60527,74135,034
Treasury Stock
-2,517-2,517-4,161-4,142-5,431-3,765
Comprehensive Income & Other
51,97561,71352,34956,0191,420-1,164
Shareholders' Equity
143,090176,124127,827125,82065,74663,551
Total Liabilities & Equity
377,437395,071370,680356,700226,405191,661
Total Debt
164,448150,081175,879159,258125,51594,403
Net Cash (Debt)
-157,953-144,944-174,973-157,355-110,254-77,205
Net Cash Per Share
-7585.77-8059.84-12095.82-11286.13-7972.68-5741.73
Filing Date Shares Outstanding
21.2321.2314.4614.2513.7713.77
Total Common Shares Outstanding
21.2321.2314.4614.2513.7713.77
Working Capital
-58,020-15,314-87,560-57,811-44,964-26,160
Book Value Per Share
6740.098296.138838.318830.454776.064616.27
Tangible Book Value
139,232171,416125,911122,68364,45161,825
Tangible Book Value Per Share
6558.408074.388705.798610.324681.974490.90
Land
64,48764,48764,48767,1492,5012,578
Buildings
144,299149,90047,13647,15446,00043,986
Machinery
87,02887,69844,84643,17844,75842,591
Construction In Progress
1,39441.7132,199120,00955,34122,792
Source: S&P Global Market Intelligence. Standard template. Financial Sources.